Overactive Bladder
The Management of Children and Adolescents with Overactive Bladder Refractory to Treatment with Parasacral Transcutaneous Electrical Nerve Stimulation.
October 18, 2024
Sexual Dysfunction in Patients with Overactive Bladder Syndrome Treated with Botulinum Toxin.
October 18, 2024
Differences in Advanced Therapeutic Modalities for Overactive Bladder in the United States by Race.
October 6, 2024
Mirabegron Versus Placebo and Other Therapeutic Modalities in the Treatment of Patients with Overactive Bladder Syndrome-A Systematic Review.
October 6, 2024
SYNCHRONIZE: Real-World Retrospective Safety Analysis of Patients Treated with OnabotulinumtoxinA for More than One Therapeutic Indication
September 30, 2024
Trends of Overactive Bladder and Pharmacologic Treatment Among U.S. Women.
September 29, 2024
Steps toward identification of a novel cue-positive overactive bladder phenotype in women with high-bother urinary urgency.
September 29, 2024
Association of Aggression with Lower Urinary Tract Symptoms and Overactive Bladder in Men: Observations from a Large Population-representative Study.
September 29, 2024
Botulinum Neurotoxin Type A in paediatric non-neurogenic therapy resistant overactive bladder: a cohort study.
September 29, 2024
A Multicenter Prospective Sham-Controlled Trial Evaluating a Physiologic Closed-Loop Wearable Tibial Neuromodulation System for Overactive Bladder (REDUCEOAB).
September 22, 2024